This investigation was undertaken for the Empire Rheumatism Council as part of a wider scheme to assess the value of gold salts in the treatment of rheumatoid arthritis. It was originally planned that the work should be carried out at various centres throughout the country, but unfortunately the war intervened and the main scheme had to be abandoned. It was found possible, however, to carry on with the experiment on a smaller scale at the ,Gardiner Institute of Medicine. The investigation was concentrated on classical cases of rheumatoid arthritis in which clinical activity was known to have been present for two to five years. In addition, women should have shown the first signs of the disease before the age of 40 and men before the age of 50. The period of observation extended over one year.
Gold therapy has been in use for a number of years, and, on the whole, the published results have been favourable. It should be pointed out, however, that in few instances has any attempt been made to control these observations, especially the psychological aspects of the treatment, in large clinics. One of the chief aims in this investigation was to neutralize the psychological effect usually associated with " having an injection." With this in view the patients were divided roughly into two equal groups, one receiving injections of myocrisin and the other an inactive control substance, identical in appearance with the gold salt and provided by the makers in similar phials. It was not made known to me which patients had received the former and which the latter until after I had completed and recorded my final observations. In this way an attempt was made to control the investigation adequately, and the results are embodied in this paper.
Historical
In 1890 Koch stated that gold cyanide in dilutions of 1: 2,000,000 inhibited the in vitro growth of the tubercle bacillus; since then many therapeutic trials have been carried out with gold salts. Junker (1913) gave gold cyanide intravenously to eleven patients with pulmonary tuberculosis, and stated that his general impression of the results was not unfavourable. Feldt (1917) Lewy and Freund (1926) with good results in streptococcal infections in man. Schmidt (1944) claimed that nearly twenty years ago he was among the first to employ gold in the treatment of the various types of arthritis and found that it had a very limited usefulness. In Stockholm, Hedenius (1926) reported good results with the use of colloidal gold in septic polyarthritis, and Lande (1927) was favourably impressed with solganal in the treatment of chronic polyarthritis. Pick (1927) , however, using triphal, found little or no improvement in his small series of patients. The use of gold salts in rheumatoid arthritis spread rapidly throughout Europe, and almost simultaneously Forestier (1929) in France, and Umber (1929 ), Zimmer (1930 ), and Feldt (1930 in Germany published independent results of chrysotherapy in this disease. Forestier stated that his attention was drawn to the use of gold salts in the treatment of some of the forms of chronic arthritis by the analogy of the clinical evolution of certain severe types of chronic rheumatism with that of tuberculosis; he (Forestier, 1935) reported that 70-80% of over 550 patients responded favourably to gold therapy.
In this country reports on the treatment of rheumatoid arthritis with gold salts began to appear in 1934. Slot and Deville (1934) and Buckley (1934) used gold salts in two small series of cases with promising results. The latter felt that there was no greater risk with gold salts than with protein shock. The following year Pemberton (1935) published encouraging results in a series of 100 patients with varying types of chronic arthritis, and concluded that the response to gold salts was roughly inversely proportional to the duration of the disease. In subsequent years an increasing number of publications on this subject made their appearance. Crosby (1936) , Bach (1936) , Crawford (1937) Gudiksen (1935) , Parr and Shipton (1937), Sundelin (1941) , and Graham and Fletcher (1943) . Sundelin Clinical Material Age and Sex.-Of the 110 patients falling into the category described, 28 were males and 82 females -a ratio of approximately 1: 3. Table 1 shows the patients in different age-groups at the onset of arthritis, but it should be remembered that no women over the age of 39 were included. It will be seen that more than half of the patients in this series fall into the age-group 30-39. 
Method of Treatment
All the patients, with one exception, had ambulatory treatment, and attended the clinic once a week for observation and injections. In addition, all received some form of physiotherapy, such as heat and massage. Before treatment was begun each patient was given a thorough clinical examination, including joint measurements, full blood count, blood sedimentation rate, blood uric acid, urine analysis, urea clearance, and radiological examination; the findings were charted on special case sheets. The same procedure was adopted at the end of the period of observation-i.e. one yearwhile during treatment weekly urine analysis, fortnightly white-blood-cell counts, and monthly blood sedimentation tests were carried out. A careful watch was kept for the first signs of intolerance to gold.
As already mentioned, roughly half the patients received myocrisin, an aqueous solution of gold sodium thiomalate containing 50% metallic gold; and half an inactive control substance. The latter contained the same constituents as the myocrisin with the exception of the gold radical, had the same appearance, and was made up in identical ampoules. As previously stated, it was not made known to me which patients had received myocrisin and which the inactive control substance until after I had completed and recorded my final observations on the progress of the disease. Both the myocrisin and the control substance were administered in the same way. Intramuscular injections were given into the buttocks at weekly intervals in the following doses: 1 x0 01, 2x0 02, l x0-05, and 9 x0 I g., giving a total of 1-0 g. in a course. If necessary, after an interval of three months a second course of 10 g. was given in the same dosage. As the period of observation was for one year only, it was not possible to give more than two courses of injections. Treatment was suspended temporarily when the milder forms of toxicity appeared, and permanently when the reactions were severe.
Results of Treatment
Of the 110 patients 61 Table 2 and of the inactive control substance in Table 3 ; the figures in parentheses in both representing the results as obtained from questioning the patient about his own opinion as to progress during the year. Blood uric acid estimations (Benedict, 1922) were carried out before and after treatment in all the patients in this series. Out ofthe 110 patients 12 had initial levels above the normal (2-4 mg./l00 c.cm.), the highest being 6-0 mg. Of these, 7 received myocrisin and 5 the inactive control substance. The final levels were within normal limits in 11 of the 12 cases, and in the twelfth the blood uric acid fell from 60 mg. to 4-4 mg. after one course of myocrlsln.
Toxic Reactions
It is a well recognized fact that the use of gold salts in the treatment of rheumatoid arthritis is not without its dangers. The incidence of toxic reactions is high, according to many observers appearing in about half the cases. The majority of reactions are of a mild nature, but fatalities have been recorded from time to time (Forestier, 1935, Ellman and Lawrence, 1935; Hartfall and Garland, 1935 and . These were usually associated with the larger dosages that were given in the earlier days of gold therapy. In the present series 75% of the 61 patients who received gold injections developed toxic manifestations (Table 5 )-a figure higher than that generally reported-but th; majority of these were mild. Seven patients had multiple reactions. Most of the reactions occurred during the first course of injections, but some appeared in the second course, and a few were delayed, making their appearance some time after the cessation of treatment. It is of interest to note that 37% of the 49 patients who were given the control substance had " toxic reactions " (Table 6 ). Skin Reactions.-These appeared in 37 of the 61 patients who received myocrisin injections, but only 2 were of a severe nature and gave rise to some anxiety. Both of these patients were admitted to hospital for a period of six weeks, but it was several months before the skin had returned to its normal condition. The remaining 35 patients had reactions of a minor character, 7 of them having pruritus only. Other skin lesions were simple erythema, macular, maculo-papular, papular, pustular, squamous, and exudative dermatitis. Some of these were accompanied by fissuring of the palms of the hands, and others by desquamation of the skin. Treatment was discontinued only temporarily in most of these cases. There were several cases of delayed reactions; in one instance a patchy exudative dermatitis appeared three months after the cessation of gold therapy. Sixteen of the 49 patients who received the inactive control substance complained of skin lesions. Of these, 10 had pruritus only; 2 a papular dermatitis; and the other 4 an erythema, a pustular rash, a seborrhoeic dermatitis, and a dermatitis infectiosa respectively. It should be pointed out that all the patients were made " skin conscious before treatment started, and were instructed to report anything out of the usual.
Mouth Lesions.-These were noticed in 7 patients who had myocrisin injections. Four of these had ulceration of the lips, cheeks, and gums, and 3 complained of soreness of the mouth without any lesions. One of the patients on the control substance stated that she had a metallic taste in her mouth during treatment.
Kidney.-A mild transient albuminuria appeared in about half of the patients in both the myocrisin and the control groups, but was not considered of sufficient importance to be included in the kidney reactions. Only 5 of the patients who received myocrisin showed any definite evidence of kidney damage. Albumin, red blood cells and casts were found in the urine and treatment was abandoned.
Two of the control patients also developed albumin and casts in the urine. The urea clearance test (McIntosh et al., 1928) was performed on all the patients in both groups in this series before and after each course of injections, but the results did not show anything of significance even in those cases in which blood and casts -were found in the urine.
Alimentary Tract.-One patient developed a colitis with blood and mucus in the stools after receiving 0-6 g. of myocrisin. This proved very resistant to treatment, and, when seen recently, 17 months after the onset, the patient stated that although the condition was much better he still had periodic attacks of diarrhoea without blood or mucus.
Blood.-A decrease in the white cell count was noticed during treatment in the majority of patients receiving myocrisin, but in no instance did it fall below 3,000 per c.mm. The count returned to its original level shortly after the end of treatment. It 3. In assessing any form of treatment it is essential that the investigation should be adequately controlled, especially from the psychological aspect.
4. Toxic reactions occurred in 75% of the patients who received myocrisin, but most of these were of a mild nature. There were no deaths in this series, and only two patients, with exfoliative dermatitis, gave rise to some degree of anxiety.
5. Gold salts are of value in the treatment of rheumatoid arthritis, particularly when used in conjunction with general, physiotherapeutic, and orthopaedic measures. On account of their toxicity they should only be employed by those with experience in their use.
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